Molecular Classification of Rhabdomyosarcoma—Genotypic and Phenotypic Determinants of Diagnosis
Top Cited Papers
Open Access
- 1 February 2009
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 174 (2), 550-564
- https://doi.org/10.2353/ajpath.2009.080631
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Global gene expression profiling of PAX‐FKHR fusion‐positive alveolar and PAX‐FKHR fusion‐negative embryonal rhabdomyosarcomasThe Journal of Pathology, 2007
- Identification of a PAX-FKHR Gene Expression Signature that Defines Molecular Classes and Determines the Prognosis of Alveolar RhabdomyosarcomasCancer Research, 2006
- Microarray Analysis and Tumor ClassificationNew England Journal of Medicine, 2006
- Examination of Gene Fusion Status in Archival Samples of Alveolar Rhabdomyosarcoma Entered on the Intergroup Rhabdomyosarcoma Study-III TrialThe Journal of Molecular Diagnostics, 2006
- Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevanceEuropean Journal of Surgical Oncology, 2004
- Consequences of Nonadaptive Alterations in CancerMolecular Biology of the Cell, 2003
- Molecular characterisation of soft tissue tumours: a gene expression studyThe Lancet, 2002
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001
- Allelotype of pediatric rhabdomyosarcomaOncogene, 1997
- Agreement among and within groups of pathologists in the classification of rhabdomyosarcoma and related childhood sarcomas. Report of an international study of four pathology classificationsCancer, 1994